Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Advanced Animal Diagnostics (Durham, NC) a commercial-stage developer of farm animal diagnostics focused on the detection of mastitis in dairy cows, closed a $11M Series B financing. Participants include Intersouth Partners and Novartis Venture Funds.

Chimerix (Durham, NC) a clinical-stage pharma company developing broad spectrum antiviral agents focusing on CMV and BK viruria, closed a $45M Series F financing. Participants include Pappas Ventures, Morningside Group, Sanderling Ventures, Canaan Partners, Alta Partners, Asset Management Co., Frazier Healthcare Ventures and New Leaf Venture Partners.

Arbor Pharmaceuticals (Atlanta, GA) a commercial-stage specialty pharmaceutical company atopic dermatitis and otic conditions, closed a $17.5M Series B financing. Participants include Signet Healthcare Partners.

nContact Surgical (Morisville, NC) a clinical-stage medical device company focused on minimally invasive hearth arrhythmias, closed a $16M Series D financing. Participants include Harbert Venture Partners, Intersouth Partners, Massey Burch, Tall Oaks Capital, Village Ventures, Finistere Ventures, Hippo Ventures and ZMV Associates.

Watermark Medical (Boca Raton, FL) a commercial-stage medical device company focused on sleep apnea, closed a $6M Series B financing. Participants include Ballast Point Ventures.

Cardioxyl Pharmaceuticals (Chapel Hill, NC) a clinical-stage small molecule company focused on acute decompensated heart failure, closed a $15M Series C financing. Participants include Aurora Funds and New Enterprise Associates.

Tigris Pharmaceuticals (Bonita Springs, FL) a clinical-stage small molecule company focused renal cell, breast and lung cancer, closed a $6.5M Series C financing. Participants include Wexford Spectrum Investors and Sonostar Capital Partners.

InVasc Therapeutics (Tucker, GA) a clinical-stage biopharmaceutical company focused on the cardiometabloic diseases chronic kidney disease and atherosclerosis, closed a $3.1M Series A financing. Participants include Trois I Investments Industriels Internationaux.

Tryton Medical (Durham, NC) a commercial-stage medical device company focused on stents designed to treat bifurcation lesions, closed a $20M Series D financing. Participants include PTV Sciences, RiverVest Venture Partners and Spray Venture Partners.

CeNeRx (Cary, NC) a clinical-stage biopharmaceutical company focused on diseases of the central nervous system, closed a $10M Series C, bringing the round total to $14M. Participants include Aisling Capital, L Capital Partners and Pappas Ventures.

Liquidia Technologies (Research Triangle Park, NC) a development-stage company focused on improving delivery of inhaled therapeutics and vaccines via nanoparticles with optimized characteristics for increased target specificity, closed a $5M Series C financing, bringing the total round to $25M. Participants include Canaan Partners, Pappas Ventures, New Enterprise Associates, Morningside, Firelake Capital and PPD

TearScience (Morrisville, NC) a clinical-stage medical device company focused on the treatment of chronic evaporative dry eye due to obstructive Meibomian Gland Dysfunction, closed a $44.5M Series C financing. Participants include Essex Woodlands Health Ventures, Investor Growth Capital, General Catalyst, De Novo Ventures, Spray Ventures and Quaker Bio Ventures.

Liquidia (Morrisville, NC) a development-stage company focused on improving delivery of inhaled therapeutics and vaccines via nanoparticles with optimized characteristics for increased target specificity, closed a $13M Series C financing, bringing the total round to $20M. Participants include Canaan Partners, Pappas Ventures, New Enterprise Associates, Morningside and Firelake Capital.

« Previous Page« Previous Entries  Next Entries »Next Page »

to top of page...